Prenylation inhibition with lonafarnib decreases hepatitis D levels in humans Koh, C., Yurdaydin, C., Cooper, S., Cory, D., Dahari, H., Haynes-Williams, V., Winters, M. A., Bys, M., Choong, I. C., Idilman, R., Keskin, O., Canini, L., Pinto, P., Wolff, E. F., Bishop, R., Kleiner, D. E., Hoofnagle, J. H., Glenn, J., Heller, T. WILEY-BLACKWELL. 2014: 1092A–1093A

View details for Web of Science ID 000344483804422